Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Angeletti C. A., Lucchi M., Fontanini G., Mussi A., Chella A., Ribechini A., Vignati S., Bevilacqua G. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence. Cancer. 1996 Aug 1;78(3):409–415. doi: 10.1002/(SICI)1097-0142(19960801)78:3<409::AID-CNCR5>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
- DMPA, zalcitabine, and the FDA. Lancet. 1992 Jul 4;340(8810):45–45. [PubMed] [Google Scholar]
- Dalquen P., Sauter G., Torhorst J., Schultheiss E., Jordan P., Lehmann S., Solèr M., Stulz P., Mihatsch M. J., Gudat F. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J Pathol. 1996 Jan;178(1):53–58. doi: 10.1002/(SICI)1096-9896(199601)178:1<53::AID-PATH415>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
- Dosaka-Akita H., Hu S. X., Fujino M., Harada M., Kinoshita I., Xu H. J., Kuzumaki N., Kawakami Y., Benedict W. F. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer. 1997 Apr 1;79(7):1329–1337. [PubMed] [Google Scholar]
- Fontanini G., Bigini D., Vignati S., Basolo F., Mussi A., Lucchi M., Chine S., Angeletti C. A., Harris A. L., Bevilacqua G. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol. 1995 Sep;177(1):57–63. doi: 10.1002/path.1711770110. [DOI] [PubMed] [Google Scholar]
- Fontanini G., Vignati S., Bigini D., Mussi A., Lucchi M., Angeletti C. A., Basolo F., Bevilacqua G. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer. 1995 May;71(5):1003–1007. doi: 10.1038/bjc.1995.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fontanini G., Vignati S., Lucchi M., Mussi A., Calcinai A., Boldrini L., Chiné S., Silvestri V., Angeletti C. A., Basolo F. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer. 1997;75(9):1295–1301. doi: 10.1038/bjc.1997.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fukuyama Y., Mitsudomi T., Sugio K., Ishida T., Akazawa K., Sugimachi K. K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Br J Cancer. 1997;75(8):1125–1130. doi: 10.1038/bjc.1997.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giatromanolaki A., Koukourakis M., O'Byrne K., Fox S., Whitehouse R., Talbot D. C., Harris A. L., Gatter K. C. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol. 1996 May;179(1):80–88. doi: 10.1002/(SICI)1096-9896(199605)179:1<80::AID-PATH547>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
- Harpole D. H., Jr, Herndon J. E., 2nd, Wolfe W. G., Iglehart J. D., Marks J. R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res. 1995 Jan 1;55(1):51–56. [PubMed] [Google Scholar]
- Harpole D. H., Jr, Richards W. G., Herndon J. E., 2nd, Sugarbaker D. J. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg. 1996 May;61(5):1470–1476. doi: 10.1016/0003-4975(96)00104-X. [DOI] [PubMed] [Google Scholar]
- Horio Y., Takahashi T., Kuroishi T., Hibi K., Suyama M., Niimi T., Shimokata K., Yamakawa K., Nakamura Y., Ueda R. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res. 1993 Jan 1;53(1):1–4. [PubMed] [Google Scholar]
- Irie K., Ishida H., Furukawa T., Koyanagi K., Miyamoto Y. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Rinsho Byori. 1996 Jan;44(1):32–41. [PubMed] [Google Scholar]
- Kashii T., Mizushima Y., Lima C. E., Noto H., Sato H., Saito H., Kusajima Y., Kitagawa M., Yamamoto K., Kobayashi M. Studies on clinicopathological features of lung cancer patients with K-ras/p53 gene alterations: comparison between younger and older groups. Oncology. 1995 May-Jun;52(3):219–225. doi: 10.1159/000227461. [DOI] [PubMed] [Google Scholar]
- Kwa H. B., Michalides R. J., Dijkman J. H., Mooi W. J. The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer. Lung Cancer. 1996 Jun;14(2-3):207–217. doi: 10.1016/0169-5002(96)00547-8. [DOI] [PubMed] [Google Scholar]
- McLaren R., Kuzu I., Dunnill M., Harris A., Lane D., Gatter K. C. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer. 1992 Oct;66(4):735–738. doi: 10.1038/bjc.1992.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mitsudomi T., Oyama T., Kusano T., Osaki T., Nakanishi R., Shirakusa T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst. 1993 Dec 15;85(24):2018–2023. doi: 10.1093/jnci/85.24.2018. [DOI] [PubMed] [Google Scholar]
- Nishio M., Koshikawa T., Kuroishi T., Suyama M., Uchida K., Takagi Y., Washimi O., Sugiura T., Ariyoshi Y., Takahashi T. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol. 1996 Feb;14(2):497–502. doi: 10.1200/JCO.1996.14.2.497. [DOI] [PubMed] [Google Scholar]
- Quinlan D. C., Davidson A. G., Summers C. L., Warden H. E., Doshi H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res. 1992 Sep 1;52(17):4828–4831. [PubMed] [Google Scholar]
- Tomisaki S., Ohno S., Ichiyoshi Y., Kuwano H., Maehara Y., Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer. 1996 Apr 15;77(8 Suppl):1722–1728. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1722::AID-CNCR46>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
- Weidner N., Folkman J. Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol. 1996:167–190. [PubMed] [Google Scholar]
- Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995 Jul;147(1):9–19. [PMC free article] [PubMed] [Google Scholar]
- Yamazaki K., Abe S., Takekawa H., Sukoh N., Watanabe N., Ogura S., Nakajima I., Isobe H., Inoue K., Kawakami Y. Tumor angiogenesis in human lung adenocarcinoma. Cancer. 1994 Oct 15;74(8):2245–2250. doi: 10.1002/1097-0142(19941015)74:8<2245::aid-cncr2820740807>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
